GCK and Insulin resistance: Based on our findings, this phenomenon may now be explained by the fact that the GCKR-GCK disruptor may have increased liver cell follistatin secretion, which in turn, may have promoted adipose tissue insulin resistance and an increase of triglyceride levels.